Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,453 | 1,535 | 1,836 | 1,498 | 1,797 |
| Income taxes - deferred | 234 | -212 | 1,227 | -331 | 487 |
| Accounts receivable | 5,391 | 1,851 | -2,228 | 864 | -2,501 |
| Other Working Capital | 4,100 | 2,424 | -660 | 2,883 | -2,534 |
| Other Operating Activity | -2,330 | -2,002 | 5,421 | 2,112 | 4,426 |
| Operating Cash Flow | $8,848 | $3,594 | $5,595 | $7,027 | $1,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -528 | -12 | -421 | -1,005 | -400 |
| Purchase Of Investment | -6 | -4 | -41 | -136 | -135 |
| Sale Of Investment | 11 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 334 | 0 | 0 | 631 |
| Investing Cash Flow | $-524 | $318 | $-462 | $-1,141 | $96 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -364 | -278 | 157 | -8,151 | -832 |
| Common Stock Repurchased | -165 | N/A | N/A | N/A | N/A |
| Dividend Paid | -3,980 | N/A | N/A | N/A | 0 |
| Other Financing Activity | 0 | -5,208 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,509 | $-5,487 | $157 | $-8,151 | $-832 |
| Exchange Rate Effect | -6 | -12 | 13 | -10 | -19 |
| Beginning Cash Position | 6,358 | 7,840 | 2,701 | 4,975 | 3,806 |
| End Cash Position | 10,322 | 6,358 | 7,840 | 2,701 | 4,844 |
| Net Cash Flow | $3,815 | $-1,574 | $5,290 | $-2,265 | $938 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,848 | 3,594 | 5,595 | 7,027 | 1,675 |
| Capital Expenditure | -618 | -658 | -595 | -1,005 | -401 |
| Free Cash Flow | 8,229 | 2,936 | 5,001 | 6,022 | 1,274 |